These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27078083)
21. Gene therapy for myocardial angiogenesis: with direct intramuscular gene transfer of naked deoxyribonucleic acid encoding vascular endothelial growth factor and cell transplantation of vascular endothelial growth factor transfected H9c2 myoblast. Sugimoto T; Inui K; Shimazaki Y Jpn J Thorac Cardiovasc Surg; 2003 May; 51(5):192-7. PubMed ID: 12776950 [TBL] [Abstract][Full Text] [Related]
22. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354 [TBL] [Abstract][Full Text] [Related]
23. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD). Kukuła K; Chojnowska L; Dąbrowski M; Witkowski A; Chmielak Z; Skwarek M; Kądziela J; Teresińska A; Małecki M; Janik P; Lewandowski Z; Kłopotowski M; Wnuk J; Rużyłło W Am Heart J; 2011 Mar; 161(3):581-9. PubMed ID: 21392615 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia. Pätilä T; Ikonen T; Rutanen J; Ahonen A; Lommi J; Lappalainen K; Krogerus L; Ihlberg L; Partanen TA; Lähteenoja L; Virtanen K; Alitalo K; Ylä-Herttuala S; Harjula A J Heart Lung Transplant; 2006 Feb; 25(2):206-13. PubMed ID: 16446222 [TBL] [Abstract][Full Text] [Related]
25. Structural stability of neoangiogenic intramyocardial microvessels supports functional recovery in chronic ischemic myocardium. Shim WS; Lim SY; Li SQ; Gu Y; Ong HC; Song IC; Chuah SC; Wong P J Mol Cell Cardiol; 2008 Jul; 45(1):70-80. PubMed ID: 18514708 [TBL] [Abstract][Full Text] [Related]
26. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Losordo DW; Vale PR; Symes JF; Dunnington CH; Esakof DD; Maysky M; Ashare AB; Lathi K; Isner JM Circulation; 1998 Dec 22-29; 98(25):2800-4. PubMed ID: 9860779 [TBL] [Abstract][Full Text] [Related]
27. Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. Nikol S; Engelmann MG; Pelisek J; Fuchs A; Golda A; Shimizu M; Mekkaoui C; Rolland PH Acta Physiol Scand; 2002 Oct; 176(2):151-9. PubMed ID: 12354175 [TBL] [Abstract][Full Text] [Related]
29. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats. Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512 [TBL] [Abstract][Full Text] [Related]
30. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Stewart DJ; Hilton JD; Arnold JM; Gregoire J; Rivard A; Archer SL; Charbonneau F; Cohen E; Curtis M; Buller CE; Mendelsohn FO; Dib N; Page P; Ducas J; Plante S; Sullivan J; Macko J; Rasmussen C; Kessler PD; Rasmussen HS Gene Ther; 2006 Nov; 13(21):1503-11. PubMed ID: 16791287 [TBL] [Abstract][Full Text] [Related]
31. Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine. Saeed M; Saloner D; Martin A; Do L; Weber O; Ursell PC; Jacquier A; Lee R; Higgins CB Radiology; 2007 May; 243(2):451-60. PubMed ID: 17384240 [TBL] [Abstract][Full Text] [Related]
36. Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2. Heilmann C; von Samson P; Schlegel K; Attmann T; von Specht BU; Beyersdorf F; Lutter G Eur J Cardiothorac Surg; 2002 Dec; 22(6):957-64. PubMed ID: 12467820 [TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432 [TBL] [Abstract][Full Text] [Related]
38. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Tao Z; Chen B; Tan X; Zhao Y; Wang L; Zhu T; Cao K; Yang Z; Kan YW; Su H Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2064-9. PubMed ID: 21245320 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA. Kim D; Ku SH; Kim H; Jeong JH; Lee M; Kwon IC; Choi D; Kim SH J Control Release; 2016 Dec; 243():182-194. PubMed ID: 27765623 [TBL] [Abstract][Full Text] [Related]
40. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]